Julia E Egido
Overview
Explore the profile of Julia E Egido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Egido J, Dekker S, Toner-Bartelds C, Lood C, Rooijakkers S, Bardoel B, et al.
Viruses
. 2023 Nov;
15(11).
PMID: 38005888
Therapeutic bacteriophages (phages) are primarily chosen based on their in vitro bacteriolytic activity. Although anti-phage antibodies are known to inhibit phage infection, the influence of other immune system components is...
2.
Egido J, Toner-Bartelds C, Costa A, Brouns S, Rooijakkers S, Bardoel B, et al.
Sci Rep
. 2023 Jan;
13(1):856.
PMID: 36646746
Bacteriophages (phages) are viruses that specifically attack bacteria. Their use as therapeutics, which constitutes a promising alternative to antibiotics, heavily relies on selecting effective lytic phages against the pathogen of...
3.
Pascha M, Thijssen V, Egido J, Linthorst M, van Lanen J, van Dongen D, et al.
ACS Chem Biol
. 2022 Aug;
17(9):2425-2436.
PMID: 35926224
Influenza A viruses pose a serious pandemic risk, while generation of efficient vaccines against seasonal variants remains challenging. There is thus a pressing need for new treatment options. We report...
4.
Egido J, Costa A, Aparicio-Maldonado C, Haas P, Brouns S
FEMS Microbiol Rev
. 2021 Sep;
46(1).
PMID: 34558600
We are in the midst of a golden age of uncovering defense systems against bacteriophages. Apart from the fundamental interest in these defense systems, and revolutionary applications that have been...
5.
San Anselmo M, Lancelot A, Egido J, Claveria-Gimeno R, Casanova A, Serrano J, et al.
Pharmaceutics
. 2020 Nov;
12(11).
PMID: 33171841
The use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such...